42 computer-programmer-"https:"-"Brookhaven-Lab"-"https:"-"https:"-"J" positions at Ulster University
Sort by
Refine Your Search
-
of the Northern Ireland Programme for Government or Sectoral Action Plans. Essential criteria Applicants should hold, or expect to obtain, a First or Upper Second Class Honours Degree in a subject relevant to the
-
for at least the three years preceding the start date of the research degree programme. Applicants who already hold a doctoral degree or who have been registered on a programme of research leading
-
areas and now wishes to further expand understanding and application of Comprehensive Innovation. This research aligns with the innovation goals in the Programme for Government 2024–2027 and the Minister
-
. It aligns with the Programme for Government 2024–2027 and positions the region as a leader in equitable, multilingual governance. The project’s outcomes—evidence-based policy recommendations
-
that they have lived in the EEA, Switzerland, the UK or Gibraltar for at least the three years preceding the start date of the research degree programme. Applicants who already hold a doctoral degree or who have
-
criteria which requires that they have lived in the EEA, Switzerland, the UK or Gibraltar for at least the three years preceding the start date of the research degree programme. Applicants who already hold a
-
for at least the three years preceding the start date of the research degree programme. Applicants who already hold a doctoral degree or who have been registered on a programme of research leading
-
considered for DfE funding if the topic aligns with the priorities of the Northern Ireland Programme for Government or Sectoral Action Plans. Essential criteria Applicants should hold, or expect to obtain, a
-
that they have lived in the EEA, Switzerland, the UK or Gibraltar for at least the three years preceding the start date of the research degree programme. Applicants who already hold a doctoral degree or who have
-
for metabolic disorders such as diabetes and obesity. However, their efficacy and safety in humans remains unexplored. This PhD programme will seek to take the first critical step towards clinical translation